Sonoma Pharmaceuticals (SNOA) Stock Chart & Stock Price History → Biden Nomination CANCELED? (From The Freeport Society) (Ad) Free SNOA Stock Alerts $0.20 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends Sonoma Pharmaceuticals Stock Price Performance5 Day Performance+0.94%1 Month Performance+33.70%3 Month Performance+32.06%6 Month Performance+16.97%Year-To-Date Performance+13.47%1 Year Performance-78.83% Receive SNOA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sonoma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. SNOA Stock Chart for Sunday, June, 2, 2024 SNOA Chart by TradingView Sonoma Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$0.21$0.20-0.15%$0.21$0.191.60 million shs$3.20 million05/30/2024$0.26$0.21-21.15%$0.26$0.206.28 million shs$3.20 million05/29/2024$0.20$0.26+28.21%$0.33$0.1953.48 million shs$4.06 million05/28/2024$0.20$0.20+2.79%$0.21$0.182.19 million shs$3.17 million05/27/2024$0.20$0.20$0.22$0.182.01 million shs$3.08 million05/24/2024$0.19$0.20+4.39%$0.22$0.181.98 million shs$3.08 million Get the Latest News and Ratings for SNOA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sonoma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$0.18$0.19+7.14%$0.19$0.161.08 million shs$2.95 million05/22/2024$0.20$0.18-11.36%$0.20$0.181.06 million shs$2.75 million05/21/2024$0.23$0.20-12.33%$0.22$0.174.71 million shs$3.11 million05/20/2024$0.24$0.23-3.81%$0.26$0.217.22 million shs$3.54 million05/17/2024$0.25$0.24-5.60%$0.30$0.1920.72 million shs$3.68 million05/16/2024$0.15$0.25+66.67%$0.27$0.1513.17 million shs$3.90 million05/15/2024$0.15$0.15-0.99%$0.15$0.15181,883 shs$2.34 million05/14/2024$0.15$0.15+1.00%$0.15$0.1481,997 shs$2.36 million05/13/2024$0.15$0.15+3.09%$0.16$0.15130,464 shs$2.34 million05/10/2024$0.15$0.15-4.58%$0.16$0.14248,489 shs$2.31 million05/09/2024$0.15$0.15+2.92%$0.16$0.15575,438 shs$2.42 million05/08/2024$0.15$0.15+0.27%$0.16$0.1562,503 shs$2.35 million05/07/2024$0.15$0.15-1.12%$0.16$0.14191,551 shs$2.34 million05/06/2024$0.16$0.15-2.69%$0.16$0.1561,918 shs$2.37 million05/03/2024$0.15$0.16+1.89%$0.17$0.1555,926 shs$2.44 million05/02/2024$0.15$0.15-0.07%$0.17$0.14250,115 shs$2.39 million05/01/2024$0.16$0.15-3.59%$0.16$0.15146,130 shs$2.39 million04/30/2024$0.16$0.16-0.75%$0.16$0.1534,030 shs$2.48 million04/29/2024$0.16$0.16+0.69%$0.17$0.15229,629 shs$2.50 million04/26/2024$0.16$0.16-0.25%$0.17$0.15108,630 shs$2.50 million04/25/2024$0.16$0.16+0.25%$0.17$0.16112,297 shs$2.50 million04/24/2024$0.16$0.16+0.63%$0.17$0.15118,904 shs$2.50 million04/23/2024$0.16$0.16+1.02%$0.16$0.15150,407 shs$2.48 million04/22/2024$0.15$0.16+4.93%$0.16$0.1591,994 shs$2.46 million04/19/2024$0.16$0.15-4.21%$0.16$0.15166,177 shs$2.34 million04/18/2024$0.17$0.16-6.84%$0.17$0.16126,627 shs$2.45 million04/17/2024$0.17$0.17+1.27%$0.18$0.16172,636 shs$2.62 million04/16/2024$0.16$0.17+2.85%$0.18$0.15231,388 shs$2.59 million04/15/2024$0.18$0.16-8.03%$0.19$0.16369,289 shs$2.52 million04/12/2024$0.17$0.18+4.34%$0.18$0.16760,930 shs$2.74 million04/11/2024$0.17$0.17-2.44%$0.18$0.16338,768 shs$2.63 million04/10/2024$0.15$0.17+12.83%$0.17$0.15765,180 shs$2.69 million04/09/2024$0.15$0.15+3.03%$0.17$0.15696,803 shs$2.39 million04/08/2024$0.15$0.15-2.63%$0.15$0.15192,809 shs$2.32 millionAre You Positioned For The New Energy Goldrush? (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it.04/05/2024$0.16$0.15-4.81%$0.17$0.15139,762 shs$2.38 million04/04/2024$0.16$0.16+1.27%$0.16$0.15702,405 shs$2.50 million04/03/2024$0.15$0.16+8.97%$0.16$0.14436,463 shs$2.47 million04/02/2024$0.15$0.15-5.35%$0.15$0.14574,088 shs$2.26 million04/01/2024$0.17$0.15-7.88%$0.16$0.15872,457 shs$2.39 million03/29/2024$0.17$0.17$0.19$0.153.32 million shs$2.60 million03/28/2024$0.17$0.17+0.73%$0.19$0.153.27 million shs$2.60 million03/27/2024$0.16$0.17+4.49%$0.18$0.153.29 million shs$2.58 million03/26/2024$0.14$0.16+12.86%$0.17$0.142.26 million shs$2.47 million03/25/2024$0.14$0.14-0.71%$0.15$0.14209,570 shs$2.19 million03/22/2024$0.13$0.14+5.22%$0.15$0.13486,576 shs$2.20 million03/21/2024$0.14$0.13-2.05%$0.14$0.13191,822 shs$2.09 million03/20/2024$0.15$0.14-5.66%$0.14$0.13492,058 shs$2.14 million03/19/2024$0.14$0.15+4.32%$0.15$0.13172,131 shs$2.26 million03/18/2024$0.14$0.14+1.24%$0.15$0.13280,005 shs$2.17 million03/15/2024$0.13$0.14+1.78%$0.14$0.13210,925 shs$2.14 million03/14/2024$0.14$0.13-1.53%$0.14$0.13242,858 shs$2.11 million03/13/2024$0.14$0.14-2.14%$0.14$0.13278,146 shs$2.14 million03/12/2024$0.15$0.14-6.04%$0.15$0.13663,523 shs$2.19 million03/11/2024$0.15$0.15-3.25%$0.16$0.14430,555 shs$2.33 million03/08/2024$0.15$0.15+0.06%$0.16$0.15305,055 shs$2.40 million03/07/2024$0.15$0.15-0.58%$0.15$0.1492,582 shs$2.40 million03/06/2024$0.16$0.15-1.40%$0.16$0.15140,289 shs$2.42 million03/05/2024$0.15$0.16+4.67%$0.16$0.15753,504 shs$2.45 million03/04/2024$0.16$0.15-3.23%$0.16$0.14313,453 shs$2.34 million03/01/2024$0.15$0.16+5.44%$0.16$0.14310,538 shs$2.42 million Related Companies: MIRA Pharmaceuticals Stock Chart Elevai Labs Stock Chart Guardion Health Sciences Stock Chart Avalo Therapeutics Stock Chart Vaxxinity Stock Chart Galera Therapeutics Stock Chart Monopar Therapeutics Stock Chart Moleculin Biotech Stock Chart Kintara Therapeutics Stock Chart Eterna Therapeutics Stock Chart Receive SNOA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sonoma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SNOA) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceThis military-backed stock “owns” AI marketPorter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWrite this ticker symbol down…StocksToTrade Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonoma Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
